mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-06 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-05 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |